| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,773 |
6,310 |
$394K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,463 |
4,722 |
$385K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
205 |
203 |
$23K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
117 |
98 |
$16K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
1,442 |
1,397 |
$15K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,480 |
1,435 |
$14K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
118 |
109 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
264 |
215 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
3,140 |
2,824 |
$7K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
23 |
16 |
$6K |
| 90688 |
|
375 |
354 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
235 |
228 |
$3K |
| 90686 |
|
163 |
159 |
$2K |
| 0011A |
|
103 |
83 |
$2K |
| 0012A |
|
97 |
81 |
$2K |
| 0013A |
|
49 |
49 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
16 |
16 |
$1K |
| 90674 |
|
56 |
52 |
$889.33 |
| 80061 |
Lipid panel |
75 |
72 |
$601.72 |
| 82274 |
|
76 |
75 |
$579.84 |
| 80305 |
|
66 |
56 |
$557.13 |
| 0064A |
|
56 |
47 |
$480.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
40 |
32 |
$292.20 |
| 99441 |
|
35 |
28 |
$247.71 |
| G0008 |
Administration of influenza virus vaccine |
224 |
208 |
$161.99 |
| S0250 |
Comprehensive geriatric assessment and treatment planning performed by assessment team |
18 |
16 |
$0.00 |
| 91301 |
|
93 |
71 |
$0.00 |
| 99397 |
|
26 |
26 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13 |
13 |
$0.00 |